133 related articles for article (PubMed ID: 11382539)
21. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.
Pettegrew JW; Keshavan MS; Panchalingam K; Strychor S; Kaplan DB; Tretta MG; Allen M
Arch Gen Psychiatry; 1991 Jun; 48(6):563-8. PubMed ID: 1898445
[TBL] [Abstract][Full Text] [Related]
22. In vitro 31P NMR spectroscopy detects altered phospholipid metabolism in Alzheimer's disease.
Miatto O; Gonzalez RG; Buonanno F; Growdon JH
Can J Neurol Sci; 1986 Nov; 13(4 Suppl):535-9. PubMed ID: 3791069
[TBL] [Abstract][Full Text] [Related]
23. Decreased energy demanding processes in the frontal lobes of schizophrenics due to neuroleptics? A 31P-magneto-resonance spectroscopic study.
Volz HP; Rzanny R; Rössger G; Hübner G; Kreitschmann-Andermahr I; Kaiser WA; Sauer H
Psychiatry Res; 1997 Dec; 76(2-3):123-9. PubMed ID: 9522404
[TBL] [Abstract][Full Text] [Related]
24. Fatty acid composition of the postmortem prefrontal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder.
Hamazaki K; Maekawa M; Toyota T; Dean B; Hamazaki T; Yoshikawa T
Psychiatry Res; 2015 Jun; 227(2-3):353-9. PubMed ID: 25858798
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of proton and phosphorus magnetic resonance spectroscopy in schizophrenia at 4 Tesla.
Théberge J; Al-Semaan Y; Jensen JE; Williamson PC; Neufeld RW; Menon RS; Schaefer B; Densmore M; Drost DJ
Psychiatry Res; 2004 Nov; 132(1):33-9. PubMed ID: 15546701
[TBL] [Abstract][Full Text] [Related]
26. Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites.
Yao Jk; Stanley JA; Reddy RD; Keshavan MS; Pettegrew JW
Biol Psychiatry; 2002 Oct; 52(8):823-30. PubMed ID: 12372654
[TBL] [Abstract][Full Text] [Related]
27. 31P magnetic resonance spectroscopy in the dorsolateral prefrontal cortex of schizophrenics with a volume selective technique--preliminary findings.
Volz HP; Rzanny R; May S; Hegewald H; Preussler B; Hajek M; Kaiser WA; Sauer H
Biol Psychiatry; 1997 Mar; 41(6):644-8. PubMed ID: 9066987
[TBL] [Abstract][Full Text] [Related]
28. Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia.
Shioiri T; Kato T; Inubushi T; Murashita J; Takahashi S
Psychiatry Res; 1994 Dec; 55(4):223-35. PubMed ID: 7701036
[TBL] [Abstract][Full Text] [Related]
29. Evidence for altered cell membrane lipid composition in postmortem prefrontal white matter in bipolar disorder and schizophrenia.
Ghosh S; Dyer RA; Beasley CL
J Psychiatr Res; 2017 Dec; 95():135-142. PubMed ID: 28843843
[TBL] [Abstract][Full Text] [Related]
30. 31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia.
Pettegrew JW; Keshavan MS; Minshew NJ
Schizophr Bull; 1993; 19(1):35-53. PubMed ID: 8451612
[TBL] [Abstract][Full Text] [Related]
31. Focal changes in brain energy and phospholipid metabolism in first-episode schizophrenia: 31P-MRS chemical shift imaging study at 4 Tesla.
Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ
Br J Psychiatry; 2004 May; 184():409-15. PubMed ID: 15123504
[TBL] [Abstract][Full Text] [Related]
32. Brain cell membrane motion-restricted phospholipids: a cerebral 31-phosphorus magnetic resonance spectroscopy study of patients with schizophrenia.
Puri BK; Counsell SJ; Hamilton G
Prostaglandins Leukot Essent Fatty Acids; 2008 Dec; 79(6):233-5. PubMed ID: 18842398
[TBL] [Abstract][Full Text] [Related]
33. A 1H-decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls.
Potwarka JJ; Drost DJ; Williamson PC; Carr T; Canaran G; Rylett WJ; Neufeld RW
Biol Psychiatry; 1999 Mar; 45(6):687-93. PubMed ID: 10187998
[TBL] [Abstract][Full Text] [Related]
34. Human crystalline lens phospholipid analysis with age.
Merchant TE; Lass JH; Meneses P; Greiner JV; Glonek T
Invest Ophthalmol Vis Sci; 1991 Mar; 32(3):549-55. PubMed ID: 2001928
[TBL] [Abstract][Full Text] [Related]
35. Molecular insights into schizophrenia.
Pettegrew JW; Minshew NJ
J Neural Transm Suppl; 1992; 36():23-40. PubMed ID: 1527518
[TBL] [Abstract][Full Text] [Related]
36. Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study.
Stanley JA; Williamson PC; Drost DJ; Carr TJ; Rylett RJ; Morrison-Stewart S; Thompson RT
Schizophr Res; 1994 Oct; 13(3):209-15. PubMed ID: 7841133
[TBL] [Abstract][Full Text] [Related]
37. Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia.
Reddy R; Keshavan MS
Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):401-5. PubMed ID: 14623493
[TBL] [Abstract][Full Text] [Related]
38. In vitro 1H-magnetic resonance spectroscopy of postmortem brains with schizophrenia.
Omori M; Pearce J; Komoroski RA; Griffin WS; Mrak RE; Husain MM; Karson CN
Biol Psychiatry; 1997 Sep; 42(5):359-66. PubMed ID: 9276076
[TBL] [Abstract][Full Text] [Related]
39. Interactions among phospholipids of guinea pig rough microsomes, effect of fat deficiency.
Soulages JL; Brenner RR
Mol Cell Biochem; 1989 Oct; 90(2):127-36. PubMed ID: 2586494
[TBL] [Abstract][Full Text] [Related]
40. Smaller frontal gray matter volume in postmortem schizophrenic brains.
Selemon LD; Kleinman JE; Herman MM; Goldman-Rakic PS
Am J Psychiatry; 2002 Dec; 159(12):1983-91. PubMed ID: 12450946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
